The Global Market for Cardiac Biomarkers, 2019 to 2024 - An $11.6 Billion Opportunity, Analyzed by Type, Application, Location of Testing, and Region - ResearchAndMarkets.com

The "Cardiac
Biomarkers Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's
offering.

The global cardiac biomarkers market was worth US$ 6.9 Billion in 2018.
Looking forward, the market value is projected to reach US$ 11.6 Billion
by 2024, expanding at a CAGR of around 9% during 2019-2024.

Over the past few years, there has been a rise in the number of patients
suffering from ACS which has created a demand for cardiac marker testing
at a global level. Other than this, rising awareness among patients and
healthcare providers about the importance of early diagnosis of various
CVDs is driving the demand for these markers.

In addition, there are numerous private and public organizations which
are investing in R&D activities to develop advanced technologies in the
field of cardiac biomarkers. For instance, blood tests for
high-sensitivity cardiac troponin I have been demonstrated to identify
patients who are at a higher risk of a second heart attack.

Moreover, high accuracy and rapid results offered by biomarker testing,
coupled with the availability of affordable cardiac point-of-care
testing, are some of the other factors which are contributing to the
growth of the market.

Market Summary

Based on the location of testing, the market has been segmented into
laboratory testing and point of care testing. Laboratory testing
currently accounts for a larger share.

Based on the application, the market has been segmented into myocardial
infarction, congestive heart failure, acute coronary syndrome,
atherosclerosis and others. Myocardial infarction currently accounts for
the highest share.

Region-wise, the market has been segmented into North America, Asia
Pacific, Europe, Middle East and Africa, and Latin America. Amongst
these, North America is the biggest market, accounting for the majority
of the global share.

Key Questions Answered

• How has the global cardiac biomarkers market performed so far and how
  will it perform in the coming years?
• What are the key regional markets in the global cardiac biomarkers
  industry?
• What is the breakup of the global cardiac biomarkers market on the
  basis of type?
• What is the breakup of the global cardiac biomarkers market on the
  basis of location of testing?
• What is the breakup of the global cardiac biomarkers market on the
  basis of application?
• What are the various stages in the value chain of the global cardiac
  biomarkers market?
• What are the key driving factors and challenges in the global cardiac
  biomarkers market?
• What is the structure of the global cardiac biomarkers market and who
  are the key players?
• What is the degree of competition in the global cardiac biomarkers
  market?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Type

5.4 Market Breakup by Location of Testing

5.5 Market Breakup by Application

5.6 Market Breakup by Region

5.7 Market Forecast

6 Market Breakup by Type

6.1 Troponins (T and I)

6.2 Myocardial Muscle Creatine Kinase (CK-MB)

6.3 Myoglobin

6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP

6.5 Ischemia Modified Albumin (IMA)

6.6 Others

7 Market Breakup by Location of Testing

7.1 Laboratory Testing

7.2 Point of Care Testing

8 Market Breakup by Application

8.1 Myocardial Infarction

8.2 Congestive Heart Failure

8.3 Acute Coronary Syndrome

8.4 Atherosclerosis

8.5 Others

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Middle East and Africa

9.5 Latin America

10 Global Cardiac Biomarkers Industry: SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 Abbott Laboratories

14.3.2 Alere Inc.

14.3.3 Beckman Coulter

14.3.4 Becton, Dickinson and Co.

14.3.5 bioMerieux

14.3.6 Bio-Rad Laboratories

14.3.7 Randox Laboratories

14.3.8 Roche Diagnostics Corporation

14.3.9 Siemens Healthcare

14.3.10 Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/mck8zs/the_global_market?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190228005430/en/